DK0571417T3 - Kombination af IGF-I og IGFBP til anabolisme - Google Patents

Kombination af IGF-I og IGFBP til anabolisme

Info

Publication number
DK0571417T3
DK0571417T3 DK92903897.4T DK92903897T DK0571417T3 DK 0571417 T3 DK0571417 T3 DK 0571417T3 DK 92903897 T DK92903897 T DK 92903897T DK 0571417 T3 DK0571417 T3 DK 0571417T3
Authority
DK
Denmark
Prior art keywords
igf
combination
mammal
igfbp
human
Prior art date
Application number
DK92903897.4T
Other languages
English (en)
Inventor
Ross G Clark
Venkat R Mukku
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24624851&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0571417(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK0571417T3 publication Critical patent/DK0571417T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Package Frames And Binding Bands (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK92903897.4T 1991-02-12 1992-01-13 Kombination af IGF-I og IGFBP til anabolisme DK0571417T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/654,436 US5187151A (en) 1991-02-12 1991-02-12 Use of binding protein with igf-i as an anabolic growth promoting agent

Publications (1)

Publication Number Publication Date
DK0571417T3 true DK0571417T3 (da) 1996-04-15

Family

ID=24624851

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92903897.4T DK0571417T3 (da) 1991-02-12 1992-01-13 Kombination af IGF-I og IGFBP til anabolisme

Country Status (10)

Country Link
US (1) US5187151A (da)
EP (1) EP0571417B1 (da)
JP (1) JPH06505235A (da)
AT (1) ATE135587T1 (da)
CA (1) CA2101340C (da)
DE (1) DE69209277T2 (da)
DK (1) DK0571417T3 (da)
ES (1) ES2085001T3 (da)
GR (1) GR3019851T3 (da)
WO (1) WO1992013556A1 (da)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681814A (en) * 1990-06-07 1997-10-28 Genentech, Inc. Formulated IGF-I Composition
US5374620A (en) * 1990-06-07 1994-12-20 Genentech, Inc. Growth-promoting composition and its use
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
US5407913A (en) * 1992-12-03 1995-04-18 Celtrix Pharmaceuticals, Inc. Method and composition for systemic treatment of tissue injury
JPH08500827A (ja) * 1992-08-26 1996-01-30 セルトリックス ファーマシューティカルズ，インコーポレイテッド 異化症状および全身性組織創傷の全身的治療方法
US5643867A (en) * 1992-08-26 1997-07-01 Celtrix Pharmaceuticals, Inc. Method for treating catabolic conditions
US5273961A (en) * 1992-09-22 1993-12-28 Genentech, Inc. Method of prophylaxis of acute renal failure
ATE143267T1 (de) * 1992-10-29 1996-10-15 Genentech Inc Methode zur behandlung oder verhütung von fettleibigkeit
CA2146973C (en) * 1992-10-29 2008-09-02 Patricia R. Segarini Uses of tgf-.beta. receptor fragment as a therapeutic agent
US6124259A (en) * 1993-01-28 2000-09-26 Celtrix Pharmaceuticals, Inc. Method for treating ophthalmic disorders with IGFBP
CA2154078A1 (en) * 1993-01-29 1994-08-04 George N. Cox Wound healing composition
US5459051A (en) * 1993-03-26 1995-10-17 Celtrix Pharmaceuticals, Inc. Methods and vectors for over-expression of ubiquitin fusion proteins in host cells
DE69431631T2 (de) * 1993-09-20 2003-07-31 Celtrix Pharmaceuticals, Inc. Behandlung von hematologischen störungen mit einem igf-1/igfbp-3 komplex
AU693489B2 (en) * 1993-11-15 1998-07-02 Celtrix Pharmaceuticals, Inc. Method of treating neurological disorders
US5824642A (en) * 1994-04-07 1998-10-20 Genentech, Inc. Treatment of partial growth hormone insensitivity syndrome
US6207640B1 (en) * 1994-04-07 2001-03-27 Genentech, Inc. Treatment of partial growth hormone insensitivity syndrome
AU713275B2 (en) * 1994-07-20 1999-11-25 Celtrix Pharmaceuticals, Inc. IGF/IGFBP complex for promoting bone formation and for regulating bone remodeling
US5712249A (en) * 1994-09-08 1998-01-27 Ciba-Geigy Corporation Use of insulin-like growth factors I and II for inhibition of inflammatory response
AUPN271195A0 (en) * 1995-05-02 1995-05-25 Bunge Meat Industries Ltd. Method of selecting livestock
US5741776A (en) * 1995-05-22 1998-04-21 Genentech, Inc. Method of administration of IGF-I
US5565428A (en) * 1995-05-22 1996-10-15 Genentech, Inc. Method of administration of IGF-I
EP0766966A3 (en) * 1995-09-08 2001-02-28 Eli Lilly And Company Method of treating insulin resistance
US5948757A (en) * 1996-03-01 1999-09-07 Celtrix Pharmaceuticals, Inc. High dose IGF-1 therapy
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
US5747273A (en) * 1996-05-07 1998-05-05 Diagnostic Systems Laboratories, Inc. Immunoassay of total insulin-like growth factor binding protein-1
AUPN999096A0 (en) * 1996-05-22 1996-06-13 Northstar Biologicals Pty Ltd Peptides, antibodies, vaccines & uses thereof
US6593290B1 (en) 1996-11-01 2003-07-15 Genentech, Inc. Treatment of inner ear hair cells
US6156728A (en) 1996-11-01 2000-12-05 Genentech, Inc. Treatment of inner ear hair cells
US6066464A (en) * 1996-12-10 2000-05-23 Diagnostic Systems Laboratories, Inc. Immunoassay of IGF family of peptides, their binding proteins and related molecules in dried whole blood filter paper spots
US5824467A (en) * 1997-02-25 1998-10-20 Celtrix Pharmaceuticals Methods for predicting drug response
US6514937B1 (en) * 1997-02-25 2003-02-04 Celtrix Pharmaceuticals, Inc. Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3
US6025368A (en) * 1997-02-25 2000-02-15 Celtrix Pharmaceuticals, Inc. Method for treating the symptoms of chronic stress-related disorders using IGF
US6015786A (en) * 1997-02-25 2000-01-18 Celtrix Pharmaceuticals, Inc. Method for increasing sex steroid levels using IGF or IGF/IGFBP-3
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
DE69835878T2 (de) * 1997-05-05 2007-04-26 Mayo Foundation For Medical Education And Research, Rochester IGFIIE/ IGFBP2 Komplex
US6548482B1 (en) 1997-05-05 2003-04-15 Mayo Foundation For Medical Education And Research Treatment of osteoporosis
US6916790B2 (en) 1997-05-05 2005-07-12 Mayo Foundation For Medical Education And Research Treatment of osteoporosis
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
US6436897B2 (en) * 1998-06-01 2002-08-20 Celtrix Pharmaceuticals, Inc. Pharmaceutical formulations for IGF/IGFBP
US6417330B1 (en) 1998-06-01 2002-07-09 Celtrix Pharmaceuticals, Inc. Insulin-like growth factor binding protein variants
CA2345642A1 (en) * 1998-10-02 2000-04-13 Celtrix Pharmaceuticals, Inc. Methods for the treatment of non-thyroid disorders
US7288516B1 (en) 1999-09-20 2007-10-30 Celtrix Pharmaceuticals, Inc. Null IGF for the treatment of cancer
PT1141014E (pt) * 1999-01-06 2005-04-29 Genentech Inc Variante mutante do factor de crescimento semelhante a insulina (igf-i)
WO2001087323A2 (en) 2000-05-16 2001-11-22 Genentech, Inc. Method for treating cartilage disorders
US20030035788A1 (en) * 2000-09-19 2003-02-20 Desmond Mascarenhas Method for use of IGF-binding protein for selective sensitization of target cells in vivo
AUPR030900A0 (en) * 2000-09-22 2000-10-12 Queensland University Of Technology Growth factor complex
IL156435A0 (en) * 2001-02-09 2004-01-04 Genentech Inc Crystallization of igf-1
US6887851B2 (en) * 2001-09-18 2005-05-03 Bioexpertise, Llc IGF-binding protein-derived peptide
AU2002324672B2 (en) * 2001-09-18 2007-11-08 Bioexpertise, Llc IGF-binding protein-derived peptide or small molecule
US6914049B2 (en) * 2001-09-18 2005-07-05 Bioexpertise, Llc IGF-binding protein-derived peptide or small molecule
DK2274978T3 (da) 2003-09-12 2015-06-15 Ipsen Biopharmaceuticals Inc Fremgangsmåder til behandling af en insulin-lignende vækstfaktor-I(IGF-I)-mangel
JP2008511838A (ja) * 2004-08-30 2008-04-17 テルシカ・インク インシュリン様成長因子欠乏疾患の診断及び治療のための方法及び装置
EP2148695B1 (en) * 2007-04-18 2014-10-15 Premacure AB Method and product for treatment and/or prevention of complications of prematurity
US10212614B2 (en) * 2015-12-31 2019-02-19 Facebook, Inc. Igniting network nodes in a multi-hop wireless network
EP3397644A4 (en) 2015-12-31 2018-12-19 Siemens Healthcare Diagnostics Inc. Non-recombinant human insulin-like growth factor binding protein concentrate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1163880B (it) * 1983-07-29 1987-04-08 Guido Vergari Fascetta di legatura
JPH0720993B2 (ja) * 1985-08-22 1995-03-08 グロペップ プロプライエタリー リミテッド 生長因子
AU627423B2 (en) * 1987-04-06 1992-08-27 Celtrix Pharmaceuticals, Inc. Human somatomedin carrier protein subunits and process for producing them
DK131988A (da) * 1988-03-11 1989-09-12 Erasmus University Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
AU1955388A (en) * 1988-04-12 1989-11-03 Synergen, Inc. Method for potentiating and inhibiting insulin-like growth factor activity
DE3822646A1 (de) * 1988-07-05 1990-01-11 Steag Ag Verfahren zur gewinnung von sphaerischen feststoffteilchen insbesondere solchen zur verwendung als strahlperlen
EP0424416B1 (en) * 1988-07-15 1995-07-19 Central Sydney Area Health Service Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex
GB8826451D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Improvements in/relating to organic compounds
IL92816A0 (en) * 1988-12-22 1990-09-17 Biogrowth Inc Recombinant dna molecules,hosts,processes and human somatomedin carrier protein-like polypeptides

Also Published As

Publication number Publication date
GR3019851T3 (en) 1996-08-31
CA2101340A1 (en) 1992-08-13
CA2101340C (en) 2003-05-06
DE69209277T2 (de) 1996-10-31
US5187151A (en) 1993-02-16
EP0571417B1 (en) 1996-03-20
WO1992013556A1 (en) 1992-08-20
EP0571417A1 (en) 1993-12-01
JPH06505235A (ja) 1994-06-16
ES2085001T3 (es) 1996-05-16
DE69209277D1 (de) 1996-04-25
ATE135587T1 (de) 1996-04-15

Similar Documents

Publication Publication Date Title
DK0571417T3 (da) Kombination af IGF-I og IGFBP til anabolisme
CA2083159A1 (en) The combination of growth hormone and insulin-like growth factor-1 enhances growth
ATE152627T1 (de) Verfahren zur anregung der immunresponz
ATE122357T1 (de) Polypeptide mit hormonwachstumsbefreiender wirkung.
NZ227787A (en) Peptides and compositions having growth hormone regulatory effects
FI900888A7 (fi) Menetelmä ja laite tasavirtapulssien ohjatuksi, paikalliseksi syöttämiseksi ihmisen ja eläimen kudoksiin
Gona Prolactin as a goitrogenic agent in amphibia
DE69327585D1 (de) Befruchtete muscheleier enthaltende zusammensetzung
DE3687551D1 (de) Implantate mit verzoegerter abgabe fuer die anwendung von rekombinanten wachstumshormonen.
IT1197570B (it) Miscele di fsh e lh da ipofisi porcine in rapporto definito
ATE343395T1 (de) Verfahren zur verabreichung von igf-1
ZA776925B (en) Automatic injecting gun for remote controlled vaccination of cattle,pigs and animals in general
DE69322958D1 (de) Stabilisiertes somatotropin zur parenteralen verabreichung
DK130572B (da) Fremgangsmåde og depotpræparat til regulering af østrustidspunktet hos hundyr af husdyrarterne kvæg, hest og svin.
ZA925909B (en) Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines
CS151887A2 (en) Method of sound, physiologically normal farming animal's mamma parenchyma's growth increase
Chadwick Induction of water drive in Triturus viridescens with anterior pituitary extract.
MY100892A (en) Veterinary preparations.
ATE153859T1 (de) Somatotropin zur erhoehung der reproduktiven leistung in rinder
PT1324764E (pt) Pprocesso para inducao do inicio do ciclo reprodutivo em animais reprodutores femininos
ATE59779T1 (de) Verfahren zur regulierung der tierischen fortpflanzung.
Cognie et al. Comparison of two FSH treatment schedules to induce superovlation in ewes
NO870768D0 (no) Tilsetningsmiddel til dyrefor, fremgangsmaate for dets fremstilling og anvendelse i forblandinger.
ES2097816T5 (es) Producto y su uso para el tratamiento de estados catabolicos que comprende ifg-1 autentico y cantidades hipocaloricas de nutrientes.
SE9303784D0 (sv) Igf